Potential for transcatheter application of antisense oligonucleotides for the treatment of vascular diseases.
Morishita
R
R
Division of Cardiovascular Medicine, Falk Cardiovascular Research Center, Stanford University School of Medicine, California 94035-5246, USA.
Gibbons
G H
GH
Dzau
V J
VJ
D000818:Animals; D002404:Catheterization; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D014652:Vascular Diseases / Q000188:drug therapy*